Torrance, California, USA – According to the latest study from MarkWide Research Duchenne Muscular Dystrophy Treatment Market indicates that the CAGR will be 10.62% between
earlier today, Sarepta Therapeutics Inc SRPT announced it would file for regulatory approval and seek accelerated FDA approval for SRP-9001 in Duchenne muscular dystrophy (DMD)
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents
Under Florida’s no-fault system, your PIP pays medical bills (typically 80%) and lost wages (about 60%) after a crash, regardless of fault, but prompt action is crucial. Get treatment within
injuredly News Provide the latest news. All News World News, Business News, Health Care, Life Style. All News Around the World Update On This Website.